ArticleClinical and molecular hepatology2025

Correspondence to editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting".

Shunda Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.